Year-end Sale % OFF 
Abstract
Heart failure is a common cardiovascular disease. The elderly have a high risk of illness. Many patients die of the disease every year. It has become a killer for all humans. Cardiovascular disease often triggers myocardial ischemia and myocardial cell apoptosis, resulting in myocardial damage and even heart failure in patients with cardiovascular disease. Related studies have shown that miRNA-19a/19b plays an important role in myocardial damage and heart failure character. The purpose of this article is to further explore the therapeutic effect of miRNA-19a/19b on heart failure and the regulation mechanism of myocardial regeneration and repair. In this paper, 40 male mice were used as experimental objects to perform ligation surgery on the coronary arteries of mice. To establish an animal model of myocardial infarction and heart failure, then inject miRNA-19a/19b reagent through the tail vein of the mouse, observe the changes of the myocardial cell and the area of the myocardial infarction by immunofluorescence PCR technology, and detect the myocardial tissue in the mouse. Specific changes in the expression of miRNA-19a/19b. The results of the study showed that miRNA-19a/19b can improve the cardiac function of mice. The cardiac function index of mice increased from the original (263.13±5.26) to (385.48±6.92), the area of myocardial infarction decreased by 27.5%, and the proliferation rate of myocardial cells increased by 18.6%, the rate of myocardial regeneration and repair increased by 20.4%. Therefore, it can be seen that miRNA-19a/19b has a significant effect on the treatment of heart failure in mice, can effectively improve heart function, and can promote the regeneration and repair of damaged myocardium, proving the feasibility of miRNA-19a/19b for cardiovascular disease.
Highlights
MiRNA-19a/19b in myocardial tissues, and found thatCardiovascular diseases, especially the damage and miRNA-19a/19b can inhibit the apoptosis of death of many cardiac functional myocardial cardiomyocytes by regulating the target gene SOCS1 organelles caused by myocardial ischemia, and other [4]
Xu found that the expression level of miRNA will be reduced after the mouse heart is damaged, which leads to the occurrence of heart failure, proving that miRNA plays an important role in the regulation of heart function [9]
The animal models of myocardial infarction and heart failure were established by ligating the coronary arteries of mice, and miRNA-19a/19b reagent was injected through the tail vein of the mouse, and the mouse cardiomyocytes were observed by immunofluorescence PCR changes and specific circumstances of myocardial infarction area
Summary
Cardiovascular diseases, especially the damage and miRNA-19a/19b can inhibit the apoptosis of death of many cardiac functional myocardial cardiomyocytes by regulating the target gene SOCS1 organelles caused by myocardial ischemia, and other [4]. Xu found that the expression level of miRNA will be reduced after the mouse heart is damaged, which leads to the occurrence of heart failure, proving that miRNA plays an important role in the regulation of heart function [9]. This article is mainly to explore the therapeutic effect of miRNA-19a/19b on heart failure and the effect on the regulation mechanism of myocardial regeneration and repair In this project, the animal models of myocardial infarction and heart failure were established by ligating the coronary arteries of mice, and miRNA-19a/19b reagent was injected through the tail vein of the mouse, and the mouse cardiomyocytes were observed by immunofluorescence PCR changes and specific circumstances of myocardial infarction area. It can be seen that the innovation in this paper maximizes the research effect and the relevant data obtained are more accurate
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Cellular and molecular biology (Noisy-le-Grand, France)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
